Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial

BACKGROUND: Cancer patients show increased morbidity with COVID-19 and need effective immunization strategies. Many healthcare regulatory agencies recommend administering ‘booster’ doses of COVID-19 vaccines beyond the standard two-dose series, for this group of patients. Therefore, studying the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Astha, Pradhan, Kith, Duva, Benjamin, Carreno, Juan Manuel, Sahu, Srabani, Thiruthuvanathan, Victor, Campbell, Sean, Gallego, Sonia, Bhagat, Tushar D, Rivera, Johanna, Choudhary, Gaurav, Olea, Raul, Sabalza, Maite, Shapiro, Lauren C, Lee, Matthew, Quinn, Ryann, Mantzaris, Ioannis, Chu, Edward, Will, Britta, Pirofski, Liise-anne, Krammer, Florian, Verma, Amit, Halmos, Balazs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129324/
https://www.ncbi.nlm.nih.gov/pubmed/36975207
http://dx.doi.org/10.7554/eLife.83694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129324/
https://www.ncbi.nlm.nih.gov/pubmed/36975207
http://dx.doi.org/10.7554/eLife.83694

Ejemplares similares